SciMar ONE Alternatives & Competitors

12 companies similar to SciMar ONE — Accelerating Drug Development with AI

Intelligencia AI

Applying machine learning in drug development

112 Series A $15.50M

New York, United States

AI Big Data +7

ONTOFORCE

Through our data and technology solutions, we transform data into actionable insights, and...

36 Series A $7.50M

Ghent, Belgium

Analytics Biotechnology +5

Inato

Matching research sites to the right clinical trial protocols, unlocking site potential wo...

81 Series A $35.30M

Paris, France

AI Health Care +2

Cognivia

Developing predictive tools to de-risk clinical drug development

26 Venture round $19.50M

Belgium

Biotechnology Health Care +2

Track all SciMar ONE competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Design Pharmaceuticals Inc.

Boundless GPCR drug discovery

3 Seed $5.00M

Cambridge, United States

Biotechnology Health Care +1

Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...

Venture round $72.40M

Biotechnology Health Care +1

Reviva Pharmaceuticals

Next Generation Therapeutics to successfully address central nervous system, metabolic and...

18 Post-IPO Equity

Cupertino, United States

Biopharma Biotechnology +2

Sorintellis

AI-Powered Pharmaceutical Portfolio Management

Montreal, Canada

AI Biotechnology +3

Ro5

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.

12 Seed

London, United Kingdom

AI Biotechnology +3

QbDVision

QbDVision is the leading Digital CMC Platform for pharmaceutical and biotech manufacturing...

52 Series A $30.00M

Austin, United States

Ariana Pharma

The leading xAI-driven drug development company

37 Series A $2.30M

Paris, France

Analytics Data Analytics +1

GEn1E Lifesciences Inc.

Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Di...

18 Series A $17.03M

Palo Alto, United States

AI Biotechnology +4

About SciMar ONE

SciMar ONE is a startup focused on accelerating drug development with AI. Founded in 2021 and headquartered in the United States, the company leverages its proprietary AI-powered solution, the DV Platform™, to enable the pharmaceutical industry to move promising therapies from the lab to the market faster. With a focus...

Business keywords

AI-powered Solution, Pharmaceutical Industry, Drug Development, DV Platform™, Development Velocity, Clinical Data, Data Mining, Cloud-based, Drug Development Acceleration, Therapies, Pharma, Data Visualization

Frequently Asked Questions

Companies similar to SciMar ONE include Intelligencia AI, ONTOFORCE, Inato, Cognivia, Design Pharmaceuticals Inc.. They work in Health Care and Pharmaceutical and share SciMar ONE's focus on drug development, pharmaceutical industry and data visualization.

Bounce Watch lists 12 companies that share SciMar ONE's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches SciMar ONE and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

SciMar ONE Profile Intelligencia AI Alternatives ONTOFORCE Alternatives Inato Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at SciMar ONE on 14 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.